Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

Orphan Diseases and the Future of BioPharma, the Focus of the 2012 Orphan Disease Forum
Apr 5 2012
WASHINGTON, D.C.(April 5, 2012)— Thought leaders from dozens of biotech and pharmaceutical corporations from across the globe will gather June 19...
The Military’s Commitment to Biofuels Is a National Security Imperative, BIO Says
Mar 29 2012
Domestic biofuel production is necessary for energy and national security, the Biotechnology Industry Organization (BIO) emphasized today in a letter to the...
BIO Testifies on Importance of Timely Passage of BsUFA and PDUFA
Mar 29 2012
Washington, D.C. (March 29, 2012) – Sara Radcliffe, Executive Vice President of Health at the Biotechnology Industry Organization (BIO), testified...
BIO Supports Permanent Reauthorization of Programs to Encourage Development of Lifesaving Medications for Children
Mar 28 2012
Washington, D.C. (March 28, 2012) – BIO President and CEO Jim Greenwood issued the following statement in support of H.R. 4274 which will reauthorize...
BIO Announces Novozymes CEO and President Steen Riisgaard as its 2012 George Washington Carver Award Recipient
Mar 28 2012
WASHINGTON, D.C. (March 28, 2012) – BIO has named Steen Riisgaard as the recipient of its 2012 George Washington Carver Award for innovation in...
BIO Opens Nominations for 2012 Biotech Humanitarian Award
Mar 28 2012
Washington, D.C. – March 22, 2012 – The Biotechnology Industry Organization(BIO) announced today that it is accepting nominations for the fourth...
BIO Applauds Congress for Passage of the Jumpstart Our Business Startups (JOBS) Act
Mar 27 2012
The Biotechnology Industry Organization (BIO) praises the House and Senate for passage of H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act. The JOBS...
2012 BIO International Convention Business Forum Looks to Host Record Breaking Number of Partnering Meetings
Mar 27 2012
WASHINGTON, DC – (March 27, 2012) – With seven FDA drug approvals this year alone and investor optimism continuing to increase, the BIO Business...
Biofuels Are the Long-Term Solution to Gas Prices; the Renewable Fuel Standard Is Key, BIO Says
Mar 27 2012
The Renewable Fuel Standard is the bedrock policy encouraging continued investment in production of biofuels, which have helped to check fuel prices at the...
BIO Praises Senate Passage of the Jumpstart Our Business Startups (JOBS) Act
Mar 22 2012
  Washington, DC (March 22, 2012) – The Biotechnology Industry Organization (BIO) applauds the Senate on the passage of H.R. 3606, the...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...